Spanish Red Biotech Pipeline

FUND. PROGRESO Y SALUD

FIBICO-19006, APP DERIVADERM

Type: Others
Therapeutic area: Blood and Lymphatic systems
Cancer
Indication: APP DERIVADERM
Phase: 1R+D
Studies location: